Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Net Income: 2016-2025

Historic Net Income for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $31.5 million.

  • Collegium Pharmaceutical's Net Income rose 237.51% to $31.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.4 million, marking a year-over-year decrease of 34.03%. This contributed to the annual value of $42.4 million for FY2024, which is 7.88% down from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Net Income is $31.5 million, which was up 162.93% from $12.0 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Net Income ranged from a high of $72.8 million in Q2 2021 and a low of -$25.0 million during Q4 2021.
  • Moreover, its 3-year median value for Net Income was $13.0 million (2023), whereas its average is $14.8 million.
  • Examining YoY changes over the last 5 years, Collegium Pharmaceutical's Net Income showed a top increase of 7,577.45% in 2021 and a maximum decrease of 459.79% in 2021.
  • Over the past 5 years, Collegium Pharmaceutical's Net Income (Quarterly) stood at -$25.0 million in 2021, then soared by 71.24% to -$7.2 million in 2022, then surged by 543.67% to $31.9 million in 2023, then slumped by 60.75% to $12.5 million in 2024, then surged by 237.51% to $31.5 million in 2025.
  • Its Net Income stands at $31.5 million for Q3 2025, versus $12.0 million for Q2 2025 and $2.4 million for Q1 2025.